About the Authors
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, Illinois, United States of America
Jacobus Pharmaceutical Company, Inc., Princeton, New Jersey, United States of America
Walter Reed Army Institute for Research, Silver Spring, Maryland, United States of America
Department of Immunology, Strathclyde Institute for Biomedical Sciences, University of Strathclyde, Scotland, United Kingdom
Krebs Institute for Biomolecular Research, Department of Molecular Biology and Biotechnology, The University of Sheffield, Sheffield, England, United Kingdom
United States Department of Agriculture, Agricultural Research Services, Animal and Natural Resources Institute, Animal Parasitic Diseases Laboratory, Beltsville, Maryland, United States of America
Department of Chemistry, University of Washington, Seattle, Washington, United States of America
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America
Department of Pediatrics, Committee on Molecular Medicines, Genetics, and Immunology and The College, University of Chicago, Chicago, Illinois, United States of America
DPJ and Jacobus Pharmaceutical Company are progressing JPC-2056 for the treatment of malaria. The other authors declare that they have no competing financial interests.
Conceived and designed the experiments: RM PR CR SM GS WM DR JD JF SQ. Performed the experiments: SM EM GS HH MK JD JF SQ SL. Analyzed the data: RM PR CR SM EM GS WM HH DR MK JD JF SQ SL. Contributed reagents/materials/analysis tools: RM PR GS WM JD SQ. Wrote the paper: RM PR CR SM EM GS WM HH DR MK JD JF SQ SL.